MedTrace Logo

Evaluation of Long Term Safety of Tesofensine in Patients With Obesity

NCT00481104 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2011-07-04

No results posted yet for this study

Summary

Purpose of the study is to evaluate the long term safety of tesofensine in obese patients

Conditions

Interventions

DRUG

Tesofensine

Sponsors & Collaborators

  • NeuroSearch A/S

    lead INDUSTRY

Principal Investigators

  • Arne V Astrup, Professor, MD · Faculty of Life Science, University of Copenhagen, Denmark

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-05-31
Primary Completion
2008-09-30
Completion
2008-11-30

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00481104 on ClinicalTrials.gov